1. Home
  2. PMVP

as 11-15-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Founded: 2013 Country:
United States
United States
Employees: N/A City: PRINCETON
Market Cap: 85.5M IPO Year: 2020
Target Price: $5.75 AVG Volume (30 days): 209.2K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.00 EPS Growth: N/A
52 Week Low/High: $1.40 - $3.47 Next Earning Date: 11-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

PMVP Daily Stock ML Predictions

Stock Insider Trading Activity of PMV Pharmaceuticals Inc. (PMVP)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Carulli Michael PMVP Chief Financial Officer Sep 11 '24 Sell $1.50 2,891 $4,346.91 88,395
Jalota Deepika PMVP Chief Development Officer Sep 11 '24 Sell $1.50 7,218 $10,852.98 118,283

Share on Social Networks: